Title |
Role of Copper Dyshomeostasis in the Pathogenesis of Parkinson’s Disease
|
---|---|
Published in |
Bulletin of Experimental Biology and Medicine, March 2018
|
DOI | 10.1007/s10517-018-4039-4 |
Pubmed ID | |
Authors |
M. N. Karpenko, E. Yu. Ilyicheva, Z. M. Muruzheva, I. V. Milyukhina, Yu. A. Orlov, L.V. Puchkova |
Abstract |
Serum concentration of copper, immunoreactive polypeptides of ceruloplasmin and its oxidase activity, and the number of copper atoms per ceruloplasmin molecule were decreased in patients with Parkinson's disease in comparison with the corresponding parameters in age-matched healthy individuals, but the ratio of apoceruloplasmin to holoceruloplasmin in patients with Parkinson's disease was similar in both groups. Treatment of blood serum with Helex 100, a high-affinity copper chelator, revealed reduced content of labile copper atoms per ceruloplasmin molecule in patients with Parkinson's disease in comparison with that in healthy controls. The mechanism underlying impaired metabolic incorporation of labile copper atoms into CP molecule is discussed as a possible cause of copper dyshomeostasis associated with Parkinson's disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 26 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 15% |
Student > Ph. D. Student | 4 | 15% |
Student > Master | 3 | 12% |
Researcher | 2 | 8% |
Professor | 1 | 4% |
Other | 2 | 8% |
Unknown | 10 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Engineering | 3 | 12% |
Nursing and Health Professions | 3 | 12% |
Biochemistry, Genetics and Molecular Biology | 3 | 12% |
Chemistry | 2 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Other | 4 | 15% |
Unknown | 10 | 38% |